Image by insearchofbalance via FlickrGSK will be updating the labeling of Avandia. It will now include safety restrictions ordered by federal health authorities because of the drug's links to heart attack.
The FDA made the changes in the fall of 2010, as part of several agenda items regarding the diabetes pill. The European Union has banned the drug.
The new U.S. label will explain that Avandia is only intended for patients who cannot control their blood sugar with any of the other diabetes medications on the market. Patients who are currently on the drug can continue taking it after consulting with their doctor.